Issn Print: 0923-7534
Publication Date: 2017/11/01
A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy
K Fizazi; A Ulys; L Sengeløv; M Moe; S Ladoire; A Thiery-Vuillemin; A Flechon; A Guida; J Bellmunt; M A Climent; S Chowdhury; H Dumez; M Matouskova; N Penel; S Liutkauskiene; L Stachurski; C N Sternberg; F Baton; N Germann; G Daugaard
Author Information: Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.